BLRX (BLRX) Stock Price & Analysis
BLRX (BLRX) fell 0.74% to USD 2.67 as of September 8, 2026 at 08:19 UTC, according to Nexqual real-time market data.
BLRX last closed at USD 2.67; the session ranged USD 2.57–2.72 on volume of 27,937 shares. Market capitalization is —, with a 52-week range of USD 2.15–4.56 (NCM). Source: Nexqual, September 8, 2026 at 08:19 UTC.
Key Statistics (as of September 8, 2026 at 08:19 UTC)
| Price | USD 2.67 |
|---|---|
| Change | ▼ 0.74% (down) |
| Previous Close | USD 2.67 |
| Open | USD 2.67 |
| Day Range | USD 2.57 – 2.72 |
| 52-Week Range | USD 2.15 – 4.56 |
| Volume | 27,937 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (BLRX)
Nexqual's technical model rates BLRX "STRONG SELL" based on 0 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 08:19 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 44.56 (neutral) |
| vs SMA50 | Below (USD 2.87) |
| MACD | -0.04 (negative) |
Analyst Ratings (BLRX)
Wall Street analysts rate BLRX "Strong Buy" based on 2 analysts, with a mean price target of USD 22 (range USD 18–26), per Nexqual as of September 8, 2026 at 08:19 UTC.
| Consensus Rating | Strong Buy |
|---|---|
| Analyst Count | 2 |
| Mean Target | USD 22 |
| High Target | USD 26 |
| Low Target | USD 18 |
| Buy / Hold / Sell | 1 / 0 / 0 |
Earnings (BLRX)
| Next Earnings Date | 2026-11-23 |
|---|---|
| EPS Estimate | USD -0.77 |
| Revenue Estimate | $500,000 |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2025-12-31 | USD 0 vs est -0.77 ▲ beat |
| 2025-09-30 | USD 0 vs est -0.54 ▲ beat |
| 2025-06-30 | USD 0 vs est -0.53 ▲ beat |
Source: Nexqual, September 8, 2026 at 08:19 UTC.
Financials & Fundamentals (BLRX)
| Total Revenue | $1.39M |
|---|---|
| Revenue Growth (YoY) | -3.30% |
| Gross Margin | +80.03% |
| Operating Margin | -1215.31% |
| Profit Margin | +0.00% |
| ROE | -55.27% |
| Debt / Equity | 47.78 |
| Current Ratio | 1.2 |
| Total Cash | $13.08M |
| Total Debt | $7.94M |
| Free Cash Flow | $-8.85M |
Source: Nexqual, September 8, 2026 at 08:19 UTC.
Ownership (BLRX)
| Insider Ownership | +3.52% |
|---|---|
| Institutional Ownership | +1.37% |
| Shares Outstanding | 4.85M |
| Float | 4.11M |
| Short % of Float | +3.09% |
Source: Nexqual, September 8, 2026 at 08:19 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CANF | Can-Fite Biopharma Ltd | USD 2.23 | ▼ 5.51% |
| CLRB | Cellectar Biosciences, Inc. | USD 2.37 | ▼ 2.47% |
| PLX | Protalix BioTherapeutics, Inc. | USD 2.67 | ▲ 3.09% |
| ALDX | Aldeyra Therapeutics, Inc. | USD 1.48 | ▼ 0.67% |
| RDHL | Redhill Biopharma Ltd. | USD 0.72 | ▼ 2.24% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 08:19 UTC. This page is informational and not investment advice.